BCM
NUVL

Bayesian Capital Management’s Nuvalent NUVL Stock Holding History

Bayesian Capital Management’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Buy
+5,500
New +$592K 0.43% 67

Other funds holding NUVL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Bayesian Capital Management's NUVL Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in Nuvalent (NUVL) in Q2 2026: 5,500 shares worth $679K. The stake represents 0.43% of the portfolio and ranks #67 among its holdings.

293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Bayesian Capital Management held 5,500 shares of Nuvalent worth $679K as of Q2 2026.
  • Nuvalent was a new Bayesian Capital Management position in Q2 2026.
  • Nuvalent made up 0.43% of Bayesian Capital Management's portfolio in Q2 2026, its #67 holding.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.